TrialAntimicrobial agents and chemotherapy2012

Presence of lamivudine or emtricitabine is associated with reduced emergence of nonnucleoside reverse transcriptase inhibitor mutations in an efavirenz-based intermittent antiretroviral treatment regimen.

Stéphanie Trancart et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.